175 related articles for article (PubMed ID: 25789519)
1. What is the influence of hormone therapy on homocysteine and crp levels in postmenopausal women?
Lakryc EM; Machado RB; Soares JM; Fernandes CE; Baracat EC
Clinics (Sao Paulo); 2015 Feb; 70(2):107-13. PubMed ID: 25789519
[TBL] [Abstract][Full Text] [Related]
2. The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C-reactive protein level in postmenopausal women.
D'Anna R; Baviera G; Corrado F; Cancellieri F; Crisafulli A; Squadrito F
Acta Obstet Gynecol Scand; 2005 May; 84(5):474-7. PubMed ID: 15842212
[TBL] [Abstract][Full Text] [Related]
3. Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women.
Davidson MH; Maki KC; Marx P; Maki AC; Cyrowski MS; Nanavati N; Arce JC
Arch Intern Med; 2000 Nov; 160(21):3315-25. PubMed ID: 11088095
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy: estrogen and progestin effects on plasma C-reactive protein concentrations.
Skouby SO; Gram J; Andersen LF; Sidelmann J; Petersen KR; Jespersen J
Am J Obstet Gynecol; 2002 May; 186(5):969-77. PubMed ID: 12015523
[TBL] [Abstract][Full Text] [Related]
5. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
[TBL] [Abstract][Full Text] [Related]
6. Does the type of hormone replacement therapy affect lipoprotein (a), homocysteine, and C-reactive protein levels in postmenopausal women?
Bukowska H; Stanosz S; Zochowska E; Millo B; Sieja K; Chełstowski K; Naruszewicz M
Metabolism; 2005 Jan; 54(1):72-8. PubMed ID: 15562383
[TBL] [Abstract][Full Text] [Related]
7. Effects of low-dose 17-beta-estradiol plus norethisterone acetate and tibolone on fasting plasma homocysteine levels in postmenopausal women.
Kaleli B; Yildirim B; Demir S; Alatas E
Acta Obstet Gynecol Scand; 2003 Dec; 82(12):1107-11. PubMed ID: 14616255
[TBL] [Abstract][Full Text] [Related]
8. Effects of intranasal 17beta-estradiol administration on serum bioactive interleukin-6 and C-reactive protein levels in healthy postmenopausal women.
Rachoń D; Suchecka-Rachoń K; Hak Ł; Myśliwska J
Menopause; 2006; 13(5):840-5. PubMed ID: 16894332
[TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy, C-reactive protein, and fibrinogen in healthy postmenopausal women.
Yilmazer M; Fenkci V; Fenkci S; Sonmezer M; Aktepe O; Altindis M; Kurtay G
Maturitas; 2003 Dec; 46(4):245-53. PubMed ID: 14625121
[TBL] [Abstract][Full Text] [Related]
10. Effect of postmenopausal hormone replacement therapy on lipoprotein and homocysteine levels in Chinese women.
Man RY; Ting LK; Fan S; Lau MM; Siow YL; Chung YH; O K
Mol Cell Biochem; 2001 Sep; 225(1-):129-34. PubMed ID: 11716354
[TBL] [Abstract][Full Text] [Related]
11. Hormone replacement therapy lowers plasma Lp(a) concentrations. Comparison of cyclic transdermal and continuous estrogen-progestin regimens.
Taskinen MR; Puolakka J; Pyörälä T; Luotola H; Bjäörn M; Kääriänen J; Lahdenperä S; Ehnholm C
Arterioscler Thromb Vasc Biol; 1996 Oct; 16(10):1215-21. PubMed ID: 8857916
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic and metabolic effects of estrogen plus progestin therapy in hypertensive postmenopausal women treated with an ACE-inhibitor or a diuretic.
Posadzy-Malaczynska A; Rajpold K; Woznicka-Leskiewicz L; Marcinkowska J
Clin Res Cardiol; 2015 Jan; 104(1):38-50. PubMed ID: 25216597
[TBL] [Abstract][Full Text] [Related]
13. Plasma homocysteine in women taking hormone replacement therapy: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial.
Barnabei VM; Phillips TM; Hsia J
J Womens Health Gend Based Med; 1999 Nov; 8(9):1167-72. PubMed ID: 10595329
[TBL] [Abstract][Full Text] [Related]
14. Estrogen plus progestin treatment: effect of different progestin components on serum markers of apoptosis in healthy postmenopausal women.
Karaflou M; Kaparos G; Rizos D; Creatsa M; Christodoulakos G; Lambrinoudaki I
Fertil Steril; 2010 Nov; 94(6):2399-401. PubMed ID: 20493474
[TBL] [Abstract][Full Text] [Related]
15. Effects of tibolone and combined 17beta-estradiol and norethisterone acetate on serum C-reactive protein in healthy post-menopausal women: a randomized trial.
Garnero P; Jamin C; Benhamou CL; Pelissier C; Roux C
Hum Reprod; 2002 Oct; 17(10):2748-53. PubMed ID: 12351557
[TBL] [Abstract][Full Text] [Related]
16. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016
[TBL] [Abstract][Full Text] [Related]
17. Effects of transdermal and oral hormone replacement therapies on monocyte chemoattractant protein-1 levels: a randomized clinical trial.
Taşçı T; Şükür YE; Özmen B; Atabekoğlu CS; Cengiz SD; Koçbulut E; Berker B; Sönmezer M
Eur J Obstet Gynecol Reprod Biol; 2014 May; 176():50-4. PubMed ID: 24655552
[TBL] [Abstract][Full Text] [Related]
18. Postmenopausal hormone replacement therapy and plasma lipoproteins.
Taskinen MR
J Intern Med; 1995 Nov; 238(5):385-7. PubMed ID: 7595177
[No Abstract] [Full Text] [Related]
19. Effect of long-term hormone replacement therapy on plasma homocysteine in postmenopausal women: a randomized controlled study.
Madsen JS; Kristensen SR; Klitgaard NA; Bladbjerg EM; Abrahamsen B; Stilgren L; Jespersen J
Am J Obstet Gynecol; 2002 Jul; 187(1):33-9. PubMed ID: 12114885
[TBL] [Abstract][Full Text] [Related]
20. Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels.
Gol M; Akan P; Dogan E; Karas C; Saygili U; Posaci C
Maturitas; 2006 Feb; 53(3):252-9. PubMed ID: 15990257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
